The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
Open accessAbstract
Aberrant TGFbeta signaling is common in human cancers and contributes to tumor metastasis. Here, we demonstrate that Gr-1+CD11b+ myeloid cells are recruited into mammary carcinomas with type II TGF beta receptor gene (Tgfbr2) deletion and directly promote tumor metastasis. Gr-1+CD11b+ cells infiltrate into the invasive front of tumor tissues and facilitate tumor cell invasion and metastasis through a process involving metalloproteinase activity. This infiltration of Gr-1+CD11b+ cells also results in increased abundance of TGF beta 1 in tumors with Tgfbr2 deletion. The recruitment of Gr-1+CD11b+ cells into tumors with Tgfbr2 deletion involves two chemokine receptor axes, the SDF-1/CXCR4 and CXCL5/CXCR2 axes. Together, these data indicate that Gr-1+CD11b+ cells contribute to TGFbeta-mediated metastasis through enhancing tumor cell invasion and metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, data from various mouse models indicate that disrupting the CXCR1/2–MDSC axis in tumours is therapeutically efficacious across a wide variety of solid cancers166–172.”
From The current state of the art and future trends in RAS-targeted cancer therapies (2022) · cites this paper as [172]
In the citing paper
“TGF-β suppresses antigen presentation by DCs, thus impairing T-cell-mediated anti-tumor responses183, and may suppress DC cell migration184,185.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [183]
In the citing paper
“TGF-β signaling suppresses processes that lead to CD8+ T cell activation and maturation, including, in APCs, expression of components of the antigen processing and presentation machinery, such as HLA/MHC175,183,202.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [183]
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J. S., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,677
Urbich, C., & Dimmeler, S. (2004) · Circulation Research · doi:10.1161/01.res.0000137877.89448.78 · Cited by 2,388
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Self-citationDependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4
Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., et al. (1999) · Science · doi:10.1126/science.283.5403.845 · Cited by 1,644
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,565
Self-citationAlmand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,340
Self-citationBurns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,264
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2005) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,197
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140
Self-citation
Flagged first, then by citations
1 of the 61 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 925
Jiang, B., Chen, W., Qin, H., Diao, W., Li, B., Cao, W., Zhang, Z., Qi, W., Gao, J., Chen, M., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.02.020 · Cited by 24
Kuonen, F., Touvrey, C., Laurent, J., & Rüegg, C. (2010) · Cytometry Part A · doi:10.1002/cyto.a.20969 · Cited by 25
Allington, T. M., & Schiemann, W. P. (2010) · Cells Tissues Organs · doi:10.1159/000320163 · Cited by 25
Flörcken, A., Takvorian, A., Singh, A., Gerhardt, A., Ostendorf, B. N., Dörken, B., Pezzutto, A., & Westermann, J. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.10.001 · Cited by 23
Different Immunoregulation Roles of Activin A Compared With TGF-β
Li, F., Long, Y., Yu, X., Tong, Y., & Gong, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.921366 · Cited by 25
A key driver to promote HCC: Cellular crosstalk in tumor microenvironment
Liu, P., Lingyu, K., Liu, Y., Li, G., Xie, J., & Lu, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1135122 · Cited by 26
Tian, M., & Schiemann, W. P. (2009) · Translational Oncology · doi:10.1593/tlo.09145 · Cited by 25
Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy
Rigamonti, N., & Bellone, M. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1216-6 · Cited by 24
Horst, E. N., Bregenzer, M. E., Mehta, P., Snyder, C. S., Repetto, T., Yang‐Hartwich, Y., & Mehta, G. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.041 · Cited by 25
Luo, A., Meng, M., Wang, G., Han, R. F., Zhang, Y., Jing, X., Zhao, L., Gu, S., & Zhao, X. (2020) · Journal of Breast Cancer · doi:10.4048/jbc.2020.23.e54 · Cited by 23
Novitskiy, S. V., Forrester, E., Pickup, M. W., Gorska, A. E., Chytil, A. M., Aakre, M. E., Polosukhina, D., Owens, P., Yusupova, D. R., Zhao, Z., et al. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0425-7 · Cited by 22
Self-citationStrait, A. A., & Wang, X. (2020) · Molecular Carcinogenesis · doi:10.1002/mc.23196 · Cited by 22
Zahraeifard, S., Xiao, Z., So, J. Y., Ahad, A., Montoya, S., Park, W. Y., Sornapudi, T., Andohkow, T., Read, A., Kedei, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50262-8 · Cited by 24
Gorczynski, R. M., Chen, Z., Erin, N., Khatri, I. A., & Podnos, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113597 · Cited by 21
Myeloid-derived suppressor cells (MDSC): Another player in the orchestra
Gimeno, R., & Barquinero, J. (2011) · Inmunología · doi:10.1016/s0213-9626(11)70015-4 · Cited by 21
Guil‐Luna, S., Mena‐Osuna, R., Navarrete‐Sirvent, C., Lopez-Sanchez, L. M., Khouadri, K., Toledano‐Fonseca, M., Mantrana, A., Guler, I., Villar, C., Díaz, C., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00264 · Cited by 21
Endothelial cell autophagy in homeostasis and cancer
Verhoeven, J., Baelen, J., Agrawal, M., & Agostinis, P. (2021) · FEBS Letters · doi:10.1002/1873-3468.14087 · Cited by 20
Bustelo, X. R. (2012) · BioEssays · doi:10.1002/bies.201200041 · Cited by 20
Is carcinoma a mesenchymal disease? The role of the stromal microenvironment in carcinogenesis
Hemmings, C. (2013) · Pathology · doi:10.1097/pat.0b013e328360b600 · Cited by 20
Decarlo, L., Mestel, C., Barcellos-Hoff, M.-H., & Schneider, R. J. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00324-15 · Cited by 20
Buenrostro, D., Kwakwa, K. A., Putnam, N. E., Merkel, A. R., Johnson, J., Cassat, J. E., & Sterling, J. A. R. (2018) · Bone · doi:10.1016/j.bone.2018.05.008 · Cited by 22
Unique Pro-Inflammatory Response of Macrophages during Apoptotic Cancer Cell Clearance
Mendoza‐Reinoso, V., Baek, D. Y., Kurutz, A., Rubin, J. R., Koh, A. J., McCauley, L. K., & Roca, H. (2020) · Cells · doi:10.3390/cells9020429 · Cited by 20
Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme
Koliaraki, V., Henriques, A. R., Prados, A., & Kollias, G. A. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190457 · Cited by 20
Melanoma immunotherapy: strategies to overcome pharmacological resistance
Trojaniello, C., Vitale, M. G., Scarpato, L., Esposito, A., & Ascierto, P. A. (2020) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2020.1745634 · Cited by 22
Holmström, M. O., Mortensen, R. E. J., Pavlidis, M. A., Martinenaite, E., Weis-Banke, S. E., Jørgensen, M. A., Bendtsen, S. K., Met, Ö., Pedersen, A. W., Donia, M., et al. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00593-5 · Cited by 22
Batista, S., Maniati, E., Reynolds, L. E., Tavora, B., Lees, D. M., Fernandez, I., Elia, G., Casanovas, O., Celso, C. L., Hagemann, T., et al. (2014) · Nature Communications · doi:10.1038/ncomms6054 · Cited by 19
Gao, X., Liu, H., He, B., & Fu, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066334 · Cited by 20
Paraneoplastic leukemoid reaction as a marker of tumor progression in non-small cell lung cancer
McCoach, C. E., Rogers, J. G., Dwyre, D. M., & Jonas, B. A. (2015) · Cancer Treatment Communications · doi:10.1016/j.ctrc.2015.03.003 · Cited by 20
Myeloid Derived Suppressor Cells
Fujimura, T., & Enk, A. (2016) · Springer eBooks · doi:10.1007/978-4-431-55855-2_11 · Cited by 19
Jiang, A., Qin, Y., & Springer, T. A. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0593 · Cited by 18
Król, M., Pawłowski, K., Dolka, I., Musielak, O., Majchrzak, K., Mucha, J., & Motyl, T. (2011) · Veterinary Research Communications · doi:10.1007/s11259-011-9489-3 · Cited by 19
Perfilyeva, Y. V., Abdolla, N., Ostapchuk, Y. O., Tleulieva, R., Krasnoshtanov, V. C., Perfilyeva, A. V., & Belyaev, N. N. (2018) · Inflammation · doi:10.1007/s10753-018-0892-6 · Cited by 19
Prakash, R., Izraely, S., Thareja, N. S., Lee, R. H., Rappaport, M., Kawaguchi, R., Sagi‐Assif, O., Ben‐Menachem, S., Meshel, T., Machnicki, M., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00297 · Cited by 19
Rani, D. S., Rajender, S., Pavani, K., Chaubey, G., Rasalkar, A. A., Gupta, N. J., Deendayal, M., Chakravarty, B., & Kumarasamy Thangaraj, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-42690-0 · Cited by 19
Zhaoa, I.-M., Xua, H.-J., Kanga, X., Zhaoa, A.-M., & Luc, L.-M. (2016) · Cited by 19
Neutrophils in cancer, a love–hate affair
Cerezo‐Wallis, D., & Ballesteros, I. (2021) · FEBS Journal · doi:10.1111/febs.16022 · Cited by 21
Chen, R., Fu, M., Zhang, G., Zhou, Y., Zhu, S., Liu, J., Wang, D., Deng, A., & Wang, Z. (2014) · Oncotarget · doi:10.18632/oncotarget.2030 · Cited by 19
Arina, A., Schreiber, K., Binder, D. C., Karrison, T. G., Liu, R. B., & Schreiber, H. W. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202498 · Cited by 19
Progress in Tumor‐Associated Macrophages: From Bench to Bedside
Wang, Y., Lin, Y., Qiao, S., Wang, J., & Wang, H. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800232 · Cited by 20
Role of bone marrow-derived cells in colon cancer: lessons from mouse model studies
Taketo, M. M. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-008-2321-3 · Cited by 18
Recruitment of myeloid cells to the tumor microenvironment supports liver metastasis
Lim, S. Y., Gordon-Weeks, A. N., Zhao, L., Tapmeier, T. T., Im, J. H., Cao, Y., Beech, J. S., Allen, P. D., Smart, S., & Muschel, R. J. (2013) · OncoImmunology · doi:10.4161/onci.23187 · Cited by 18
Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders
Barnie, P. A., Zhang, P., Lv, H., Wang, D., Su, X., Su, Z., & Xu, H. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.4018 · Cited by 19
Model of vascular desmoplastic multispecies tumor growth
Ng, C. F., & Frieboes, H. B. (2017) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2017.05.013 · Cited by 18
Nachmany, I., Bogoch, Y., Sivan, A., Amar, O., Bondar, E., Zohar, N., Yakubovsky, O., Fainaru, O., Klausner, J. M., & Pencovich, N. (2019) · The FASEB Journal · doi:10.1096/fj.201801733r · Cited by 18
Gao, Q., Jiang, J., Chu, Z., Lin, H., Zhou, X., & Liang, X. (2017) · Oncology Letters · doi:10.3892/ol.2017.5679 · Cited by 17
Shaw, A. K., Pickup, M. W., Chytil, A. M., Aakre, M. E., Owens, P., Moses, H. L., & Novitskiy, S. V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117908 · Cited by 17
Self-citationThe Complexities of TGF-β Action During Mammary and Squamous Cell Carcinogenesis
Connolly, E. C., & Akhurst, R. J. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111798808284 · Cited by 20
Potent Immunosuppression by a Bivalent Molecule Binding to CD200R and TGF-βR
Gorczynski, R. M., Chen, Z., Shivagnahnam, S., Taseva, A., Wong, K. K. W., Yu, K., & Khatri, I. A. (2010) · Transplantation · doi:10.1097/tp.0b013e3181e2d6a1 · Cited by 17
Dhar, S., Chakravarti, M., Ganguly, N., Saha, A., Dasgupta, S., Bera, S., Sarkar, A., Roy, K., Das, J., Bhuniya, A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1303959 · Cited by 16
Inflammation and tumor microenvironment.
Niu, T., & Zhou, F. (2023) · PubMed Central · doi:10.11817/j.issn.1672-7347.2023.230231 · Cited by 17
C/EBP-δ positively regulates MDSC expansion and endothelial VEGFR2 expression in tumor development
Min, Y., Li, J., Qu, P., & Lin, P. C. (2017) · Oncotarget · doi:10.18632/oncotarget.16410 · Cited by 16
Self-citationPollard, B. S., Suckow, M. A., Wolter, W. R., Starr, J. M., Eidelman, O., Dalgard, C. L., Kumar, P., Battacharyya, S., Srivastava, M., Biswas, R., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00630 · Cited by 16
Dong, M., Xu, T., Li, H., & Li, X. (2021) · Oncology Letters · doi:10.3892/ol.2021.12629 · Cited by 16
Mohamedali, K. A., Cao, Y. J., Cheung, L. H., Hittelman, W. N., & Rosenblum, M. G. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0165 · Cited by 16
Hamilton, M. J., Banáth, J. P., Lam, V., LePard, N. E., Krystal, G., & Bennewith, K. L. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1125-0 · Cited by 17
Zhang, D., Song, Q., Wang, W., Li, Q., Zhao, Z., Jiang, Y., & Luan, Y. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202315447 · Cited by 15
El‐Ashmawy, N. E., Khedr, E. G., El‐Bahrawy, H. A., & Al-Tantawy, S. M. (2017) · Tumor Biology · doi:10.1177/1010428317692254 · Cited by 16
Lu, Z., Ding, L., Ding, H., Hao, F., Pu, Y., Wang, Y., Chen, S., Yang, Y. T., Zhao, X., Huang, X., et al. (2019) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12888 · Cited by 15
Luo, W., Xiang, W., Gan, L., Che, J., Li, J., Wang, Y., Han, L., Gu, R., Ye, L., Wang, R., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03431-6 · Cited by 15
Han, M., Xu, J., Bi, Y., Jiang, M., Xu, X., Liu, Q., & Jia, J. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1299-7 · Cited by 15
Tumour Microenvironment: Overview with an Emphasis on the Colorectal Liver Metastasis Pathway
Giakoustidis, A. E., Mudan, S., & Hagemann, T. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0155-5 · Cited by 16
Parathyroid hormone-related protein in breast cancer bone metastasis
Johnson, R. W., Rhoades, J., & Martin, T. J. (2022) · Vitamins and hormones · doi:10.1016/bs.vh.2022.04.006 · Cited by 14
New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?
Rapti, V., Τσαγανός, Θ., Vathiotis, I. A., Syrigos, N. K., Li, P., & Poulakou, G. (2022) · Vaccines · doi:10.3390/vaccines10101607 · Cited by 16
MDSCs: The Key Players in the Formation of Pre-Metastatic Niche
Cui, W., Wang, Z., Lv, J., Qin, Y., & Shi, H. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2803058 · Cited by 14
Cook, L. M., Cao, X., Dowell, A. E., Debies, M. T., Edmonds, M. D., Beck, B. H., Kesterson, R. A., Desmond, R. A., Frost, A. R., Hurst, D. R., et al. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9452-x · Cited by 14
MicroRNA‑214 promotes the EMT process in melanoma by downregulating CADM1 expression
Wang, S., Li, W., Wen, C., Diao, Y., & Zhao, T.-L. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11446 · Cited by 14
Barrett’s Esophagus: Emerging Knowledge and Management Strategies
Bhardwaj, A., Stairs, D. B., Mani, H., & McGarrity, T. J. (2012) · Pathology Research International · doi:10.1155/2012/814146 · Cited by 14
T cell- but not tumor cell-produced TGF-β1 promotes the development of spontaneous mammary cancer
Sarkar, A., Donkor, M. K., & Li, M. O. (2011) · Oncotarget · doi:10.18632/oncotarget.403 · Cited by 15
Quail, D. F., & Joyce, J. A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00019-6 · Cited by 14
Toh, B., Toh, B., Abastado, J., & Abastado, J. (2012) · OncoImmunology · doi:10.4161/onci.22196 · Cited by 15
MDSCs in pregnancy and pregnancy-related complications: an update
Shah, N. K., Xu, P., Shan, Y., Chen, C., Xie, M., Li, Y., Meng, Y., Shu, C., Dong, S., & He, J. (2022) · Biology of Reproduction · doi:10.1093/biolre/ioac213 · Cited by 13
Jiménez, M. C., Prieto, K., Lasso, P., Gutiérrez, M., Rodríguez-Pardo, V. M., Susana Fiorentino, G., & Barreto, A. (2022) · Heliyon · doi:10.1016/j.heliyon.2023.e14148 · Cited by 13
High-Risk Neuroblastoma Challenges and Opportunities for Antibody-Based Cellular Immunotherapy
Persaud, N. V., Park, J. A., & Cheung, N. V. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164765 · Cited by 13
Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?
Bhatia, D., Dolcetti, R., & Mazzieri, R. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03359-x · Cited by 12
Breast Cancer Liver Metastasis
Tabariès, S., & Siegel, P. M. (2011) · Cancer metastasis · doi:10.1007/978-94-007-0292-9_10 · Cited by 13
Immune Regulation of the Metastatic Process
Pulido, Á. D. M., & Ruffell, B. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.05.004 · Cited by 13
Can Tissue-Based Immune Markers be Used for Studying the Natural History of Cancer?
Koshiol, J. E., & Lin, S. (2012) · Annals of Epidemiology · doi:10.1016/j.annepidem.2012.03.001 · Cited by 13
Yu, Y., Wang, Y., Wang, Y., Wang, X., Liu, Y., Wang, J., Du, C., Wang, L., Li, M., Luo, F., et al. (2016) · Scientific Reports · doi:10.1038/srep34239 · Cited by 13
Vitiello, G. A. F., Amarante, M. K., Hirata, B. K. B., Campos, C. Z., de Oliveira, K. B., Guembarovski, R. L., & Watanabe, M. A. E. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05370-1 · Cited by 13
Johnson, B. (2023) · Cancers · doi:10.3390/cancers15225484 · Cited by 14
Escape Mechanisms from Antiangiogenic Therapy: An Immune Cell’s Perspective
Rivera, L. B., Pandika, M. M., & Bergers, G. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_4 · Cited by 12
Chronic hepatitis B surface antigen seroclearance‐related immune factors
Yuan, T., Jiang, Y., Li, M., & Li, W. (2016) · Hepatology Research · doi:10.1111/hepr.12726 · Cited by 12
Takeuchi, H., Konnai, S., Maekawa, N., Takagi, S., Ohta, H., Sasaki, N., Kim, S., Okagawa, T., Suzuki, Y., Murata, S., et al. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.656715 · Cited by 14
Methods to Study Metastasis in Genetically Modified MicePreprint
Kabeer, F., Beverly, L. J., Darrasse-Jèze, G., & Podsypanina, K. (2016) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top069948 · Cited by 12
Govindarajan, B., Sbrissa, D., Pressprich, M., Kim, S., Rishi, A. K., Vaishampayan, U. N., Cher, M. L., & Chinni, S. R. (2023) · Scientific Reports · doi:10.1038/s41598-023-47633-4 · Cited by 11
Guo, Y., Zhang, Y., Guan, Y., Chen, N., Zhao, M., Li, Y., Zhou, T., Zhang, X., Zhu, F., Guo, C., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113787 · Cited by 11
A key regulator of tumor-associated neutrophils: the CXCR2 chemokine receptor
Kang, W., Wang, C., Wang, M., Liu, M., Hu, W., Liang, X., Yang, J., & Zhang, Y. (2024) · Journal of Molecular Histology · doi:10.1007/s10735-024-10260-y · Cited by 12
Bone marrow immune cells and drug resistance in acute myeloid leukemia
Zhang, M., Yang, Y., Liu, J., Guo, L., Guo, Q., & Liu, W. (2025) · Experimental Biology and Medicine · doi:10.3389/ebm.2025.10235 · Cited by 11
Dormancy in the Tumor Microenvironment
Omokehinde, T., & Johnson, R. W. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73119-9_2 · Cited by 11
Cancer invasion and metastasis: Insights from murine pubertal mammary gland morphogenesis
Githaka, J. M., Pirayeshfard, L., & Goping, I. S. (2023) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2023.130375 · Cited by 10
Hareendran, S., Yang, X.-Y., Lou, H., Xiao, L., & Loh, Y. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225725 · Cited by 11
Qian, F., & Han, B. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001124 · Cited by 11
Fu, C., Lu, Y., Zhang, Y., Yu, M., Ma, S., & Lyu, S. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2510 · Cited by 12
The roles of polymorphonuclear myeloid-derived suppressor cells in endometriosis
Satake, E., Koga, K., Takamura, M., Izumi, G., Elsherbini, M., Taguchi, A., Makabe, T., Takeuchi, A., Harada, M., Hirata, T., et al. (2021) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2021.103371 · Cited by 11
Chapter 2 Managing Tumor Angiogenesis
Cuevas, I., & Boudreau, N. J. (2009) · Advances in cancer research · doi:10.1016/s0065-230x(09)03002-4 · Cited by 12
Role played by MDSC in colitis-associated colorectal cancer and potential therapeutic strategies
Wang, K., Wang, Y., & Yin, K. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05755-w · Cited by 13
Immune Modulation by Myeloid-Derived Suppressor Cells in Diabetic Kidney Disease
Hsieh, C., Chang, C., Hsu, Y., & Lin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113263 · Cited by 10
Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe?
Sadri, M., Najafi, A., Rahimi, A. R., Behranvand, N., Kazemi, M. H., Khorramdelazad, H., & Falak, R. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110470 · Cited by 12
Dual roles of myeloid-derived suppressor cells in various diseases: a review
Nepal, M. R., Shah, S., & Kang, K. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01504-2 · Cited by 11
Tumor Immunology: Basic and Clinical Advances
Beatty, P. L., Cascio, S., & Lutz, E. R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0717 · Cited by 10
Metadata
- Authors
- Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., & Moses, H. L.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Moses, Harold L.
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 13
- Issue
- 1
- Pages
- 23-35
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC2245859
- OpenAlex
- W2130870648
- Cited by
- 918
- References
- 61
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 30 · 2023: 25 · 2022: 41 · 2021: 58 · 2020: 41 · 2019: 52 · 2018: 42 · 2017: 47 · 2016: 62 · 2015: 59 · 2014: 64 · 2013: 78 · 2012: 77
- FWCI
- 29.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Veterans Affairs (IK6 BX005225)
- Vanderbilt University
- National Cancer Institute (CA068485, CA 085492, R01CA085492, R01CA116021, CA102162, R01CA108856, CA126505, R01CA076321, R01CA034590, P50CA098131, R01CA102162, CA108856, P30CA068485, U54CA126505)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK58404, P30DK058404)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- TGF-beta signaling, breast cancer, tumor-associated macrophages, metastasis, tumor invasion, metalloproteinase activity, SDF-1/CXCR4 axis, chemokine receptors, myeloid cell recruitment
- MeSH terms
- Receptor, Transforming Growth Factor-beta Type II, Animals, Breast Neoplasms, Female, Humans, Models, Biological, Neoplasm Invasiveness, Neoplasm Metastasis, Signal Transduction, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Gene Deletion, Receptors, Transforming Growth Factor beta, Matrix Metalloproteinases, Myeloid Cells, CD11b Antigen, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review